Anza Therapeutics' Unattributed VC Round

Anza Therapeutics raised a round of funding on November 06, 2007. Investors include Sofinnova Partners.

Anza Therapeutics is developing active immunotherapies for the treatment of infectious diseases and cancer. Anza's therapeutic agents are based on its proprietary live-attenuated and Killed But Metabo…

Articles about Anza Therapeutics' Unattributed VC Round: